FOLR3
gene geneOn this page
Also known as FR-GFRγ
Summary
FOLR3 (folate receptor gamma, HGNC:3795) is a protein-coding gene on chromosome 11q13.4, encoding Folate receptor gamma (P41439). Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate to the interior of cells.
This gene encodes a member of the folate receptor (FOLR) family of proteins, which have a high affinity for folic acid and for several reduced folic acid derivatives, and mediate delivery of 5-methyltetrahydrofolate to the interior of cells. Expression of this gene may be elevated in ovarian and primary peritoneal carcinoma. This gene is present in a gene cluster on chromosome 11. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 2352 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 33 total
- MANE Select transcript:
NM_000804
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:3795 |
| Approved symbol | FOLR3 |
| Name | folate receptor gamma |
| Location | 11q13.4 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FR-G, FRγ |
| Ensembl gene | ENSG00000110203 |
| Ensembl biotype | protein_coding |
| OMIM | 602469 |
| Entrez | 2352 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 7 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000545379, ENST00000546166, ENST00000611028, ENST00000612844, ENST00000622388, ENST00000897859, ENST00000897860, ENST00000946849, ENST00000946850
RefSeq mRNA: 2 — MANE Select: NM_000804
NM_000804, NM_001412270
CCDS: CCDS73344
Canonical transcript exons
ENST00000611028 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001267095 | 72135947 | 72136120 |
| ENSE00003735859 | 72139347 | 72139482 |
| ENSE00003738872 | 72139587 | 72139892 |
| ENSE00003752652 | 72135725 | 72135768 |
| ENSE00003752856 | 72138961 | 72139149 |
Expression profiles
Bgee: expression breadth ubiquitous, 164 present calls, max score 92.50.
FANTOM5 (CAGE): breadth broad, TPM avg 2.6922 / max 452.2166, expressed in 413 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 115720 | 0.9364 | 93 |
| 115716 | 0.8682 | 274 |
| 115717 | 0.3582 | 75 |
| 115719 | 0.3522 | 65 |
| 115718 | 0.1772 | 66 |
Top tissues by expression
285 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 92.50 | gold quality |
| blood | UBERON:0000178 | 91.20 | gold quality |
| monocyte | CL:0000576 | 89.77 | gold quality |
| bone marrow | UBERON:0002371 | 89.51 | gold quality |
| mononuclear cell | CL:0000842 | 89.32 | gold quality |
| leukocyte | CL:0000738 | 89.26 | gold quality |
| stromal cell of endometrium | CL:0002255 | 88.70 | gold quality |
| spleen | UBERON:0002106 | 84.82 | gold quality |
| bone marrow cell | CL:0002092 | 84.47 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 79.35 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 79.11 | gold quality |
| triceps brachii | UBERON:0001509 | 77.24 | gold quality |
| gluteal muscle | UBERON:0002000 | 77.06 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.03 | gold quality |
| metanephros cortex | UBERON:0010533 | 74.77 | gold quality |
| periodontal ligament | UBERON:0008266 | 72.77 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 71.59 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 70.62 | gold quality |
| kidney | UBERON:0002113 | 70.58 | gold quality |
| upper lobe of lung | UBERON:0008948 | 70.30 | gold quality |
| right lung | UBERON:0002167 | 69.67 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 68.66 | gold quality |
| heart right ventricle | UBERON:0002080 | 68.17 | gold quality |
| olfactory bulb | UBERON:0002264 | 67.98 | gold quality |
| type B pancreatic cell | CL:0000169 | 67.72 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 67.72 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 67.54 | gold quality |
| vastus lateralis | UBERON:0001379 | 67.19 | gold quality |
| cortex of kidney | UBERON:0001225 | 66.61 | gold quality |
| renal medulla | UBERON:0000362 | 66.57 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-55 | yes | 2084.63 |
| E-ANND-3 | yes | 11.13 |
| E-CURD-112 | yes | 8.81 |
| E-MTAB-9801 | yes | 6.74 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): SP1
Literature-anchored findings (GeneRIF, showing 7)
- The rare alleles of specific single nucleotide polymorphisms within the FOLR1, FOLR2, and FOLR3 genes were statistically significant for association with meningomyelocele. (PMID:20683905)
- We identified eight novel variants in SLC19A1 and twelve novel variants in FOLR1, FOLR2, and FOLR3. Pathogenic variants include c.1265delG in SLC19A1 resulting in an early stop codon, four large insertion deletion variants in FOLR3, and a stop_gain variant in FOLR3 (PMID:28948692)
- Plasma Homocysteine Concentration is Associated with the Expression Level of Folate Receptor 3. (PMID:32581311)
- A folate receptor 3 SNP promotes mitochondria-induced clonogenicity of CML leukemia cells: Implications for treatment free remission. (PMID:33634983)
- A Novel Immunomodulatory Mechanism by Which Vitamin D Influences Folate Receptor 3 Expression to Reduce COVID-19 Severity. (PMID:36192006)
- Secreted folate receptor gamma drives fibrogenesis in metabolic dysfunction-associated steatohepatitis by amplifying TGFbeta signaling in hepatic stellate cells. (PMID:37756380)
- Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma. (PMID:38273401)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | folr | ENSDARG00000102442 |
Paralogs (4): FOLR1 (ENSG00000110195), RTBDN (ENSG00000132026), FOLR2 (ENSG00000165457), IZUMO1R (ENSG00000183560)
Protein
Protein identifiers
Folate receptor gamma — P41439 (reviewed: P41439)
Alternative names: Folate receptor 3
All UniProt accessions (3): P41439, A0A087WYI3, F5H2G8
UniProt curated annotations — full annotation on UniProt →
Function. Binds to folate and reduced folic acid derivatives and mediates delivery of 5-methyltetrahydrofolate to the interior of cells. Isoform Short does not bind folate.
Subcellular location. Secreted.
Tissue specificity. Spleen, thymus, bone marrow, ovarian carcinoma, and uterine carcinoma.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. Variant in position: 150:MSAHPTWGPGSGRSTRAGAKSAF->ECSPNLGPWIRQVNQSWRKERILNVPLCKEDCERW WEDCRTSYTCKSNWHKGWNWTSGINECPAGALCSTFESYFPTPAALCEGLWSHSFKVSNYSRG.
Similarity. Belongs to the folate receptor family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P41439-1 | 1, Long | yes |
| P41439-4 | 2 |
RefSeq proteins (2): NP_000795, NP_001399199 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004269 | Folate_rcpt | Family |
| IPR018143 | Folate_rcpt-like | Domain |
Pfam: PF03024
UniProt features (23 total): disulfide bond 8, binding site 5, glycosylation site 3, splice variant 2, sequence conflict 2, signal peptide 1, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P41439-F1 | 90.27 | 0.79 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (5): 103; 107; 124–128; 157–162; 196
Disulfide bonds (8): 37–65, 57–105, 66–109, 89–175, 96–146, 135–209, 139–189, 152–169
Glycosylation sites (3): 121, 161, 201
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6798695 | Neutrophil degranulation |
MSigDB gene sets: 91 (showing top):
GOBP_SINGLE_FERTILIZATION, MODULE_328, REACTOME_INNATE_IMMUNE_SYSTEM, GOCC_SECRETORY_GRANULE, GOBP_MODIFIED_AMINO_ACID_TRANSPORT, MODULE_64, GOBP_MEMBRANE_FUSION, GOBP_PLASMA_MEMBRANE_ORGANIZATION, GOCC_CELL_SURFACE, chr11q13, GOBP_ORGANIC_ACID_TRANSPORT, GOBP_SPERM_EGG_RECOGNITION, GOBP_ORGANIC_ANION_TRANSPORT, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_DICARBOXYLIC_ACID_TRANSPORT
GO Biological Process (4): cell adhesion (GO:0007155), fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342), folic acid transport (GO:0015884), sperm-egg recognition (GO:0035036)
GO Molecular Function (3): folic acid binding (GO:0005542), signaling receptor activity (GO:0038023), protein binding (GO:0005515)
GO Cellular Component (6): extracellular region (GO:0005576), external side of plasma membrane (GO:0009897), membrane (GO:0016020), extrinsic component of membrane (GO:0019898), specific granule lumen (GO:0035580), tertiary granule lumen (GO:1904724)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Innate Immune System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| single fertilization | 2 |
| cellular process | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| dicarboxylic acid transport | 1 |
| vitamin transport | 1 |
| modified amino acid transport | 1 |
| cell-cell recognition | 1 |
| vitamin binding | 1 |
| carboxylic acid binding | 1 |
| modified amino acid binding | 1 |
| heterocyclic compound binding | 1 |
| molecular transducer activity | 1 |
| binding | 1 |
| plasma membrane | 1 |
| cell surface | 1 |
| side of membrane | 1 |
| membrane | 1 |
| secretory granule lumen | 1 |
| specific granule | 1 |
| intracellular organelle lumen | 1 |
| tertiary granule | 1 |
Protein interactions and networks
STRING
826 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FOLR3 | FOLH1 | Q04609 | 798 |
| FOLR3 | TFRC | P02786 | 688 |
| FOLR3 | EGFR | P00533 | 685 |
| FOLR3 | SLC46A1 | Q96NT5 | 666 |
| FOLR3 | CD44 | P16070 | 591 |
| FOLR3 | IZUMO1 | Q8IYV9 | 573 |
| FOLR3 | ERBB2 | P04626 | 571 |
| FOLR3 | EPCAM | P16422 | 560 |
| FOLR3 | SLC19A1 | P41440 | 536 |
| FOLR3 | MUC1 | P13931 | 534 |
| FOLR3 | TCN1 | P20061 | 518 |
| FOLR3 | MTHFR | P42898 | 518 |
| FOLR3 | SLC25A32 | Q9H2D1 | 515 |
| FOLR3 | MSLN | Q13421 | 507 |
| FOLR3 | GART | P22102 | 480 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FOLR3 | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOLR3 | ANKRD11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FOLR3 | FOLR2 | psi-mi:“MI:0914”(association) | 0.350 |
| UBQLN1 | FOLR3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ANKRD11 | FOLR3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (7): UBQLN1 (Two-hybrid), ANKRD11 (Two-hybrid), FOLR2 (Affinity Capture-MS), TRIM68 (Affinity Capture-MS), FBXO2 (Affinity Capture-MS), FOLR3 (Two-hybrid), FOLR3 (Two-hybrid)
ESM2 similar proteins: A2X2H7, A2XHZ9, A9SV59, F4HXW9, F4IAX0, F4IAX1, O04500, O23349, O80844, P0DO00, P41439, P45582, P50699, P51577, Q0DZ85, Q10JL1, Q10NX8, Q53MB8, Q5DWG1, Q5E9U1, Q5N8X6, Q60E70, Q6Z4G7, Q6Z4G8, Q6Z6K4, Q75IW1, Q7XR91, Q84TW8, Q8GZ17, Q8H1E6, Q8H1H9, Q8L8Q7, Q8W3E8, Q93Z08, Q94KT8, Q94LR4, Q99571, Q9C6E4, Q9FE06, Q9FHM9
Diamond homologs: A6ND01, F1M928, P02702, P02752, P14207, P15328, P35846, P41439, P86009, Q05685, Q9EQF4, Q5DRQ5, P85896
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 7 |
| Likely benign | 10 |
| Benign | 14 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
444 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:72136118:CAGG:C | donor_loss | 1.0000 |
| 11:72136119:AGGT:A | donor_loss | 1.0000 |
| 11:72136120:GG:G | donor_loss | 1.0000 |
| 11:72136121:G:A | donor_loss | 1.0000 |
| 11:72136122:T:A | donor_loss | 1.0000 |
| 11:72138959:A:AG | acceptor_gain | 1.0000 |
| 11:72138960:G:GT | acceptor_gain | 1.0000 |
| 11:72138960:GT:G | acceptor_gain | 1.0000 |
| 11:72138960:GTGC:G | acceptor_gain | 1.0000 |
| 11:72138960:GTGCA:G | acceptor_gain | 1.0000 |
| 11:72139341:A:AG | acceptor_gain | 1.0000 |
| 11:72139342:C:G | acceptor_gain | 1.0000 |
| 11:72139342:CTCA:C | acceptor_loss | 1.0000 |
| 11:72139345:A:AG | acceptor_gain | 1.0000 |
| 11:72139345:AG:A | acceptor_gain | 1.0000 |
| 11:72139346:G:A | acceptor_gain | 1.0000 |
| 11:72139346:G:GG | acceptor_gain | 1.0000 |
| 11:72139346:GGT:G | acceptor_gain | 1.0000 |
| 11:72139346:GGTC:G | acceptor_gain | 1.0000 |
| 11:72139346:GGTCA:G | acceptor_gain | 1.0000 |
| 11:72139480:CAGG:C | donor_loss | 1.0000 |
| 11:72139481:AGG:A | donor_loss | 1.0000 |
| 11:72139483:G:GG | donor_gain | 1.0000 |
| 11:72139484:T:G | donor_loss | 1.0000 |
| 11:72139496:GAGA:G | donor_gain | 1.0000 |
| 11:72136103:G:GT | donor_gain | 0.9900 |
| 11:72138956:CCCAG:C | acceptor_loss | 0.9900 |
| 11:72138957:CCAGT:C | acceptor_loss | 0.9900 |
| 11:72138958:CA:C | acceptor_loss | 0.9900 |
| 11:72138959:A:C | acceptor_loss | 0.9900 |
AlphaMissense
1646 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:72138972:G:C | W60C | 0.991 |
| 11:72138972:G:T | W60C | 0.991 |
| 11:72139140:G:C | W116C | 0.990 |
| 11:72139140:G:T | W116C | 0.990 |
| 11:72139733:T:C | F214L | 0.990 |
| 11:72139735:T:A | F214L | 0.990 |
| 11:72139735:T:G | F214L | 0.990 |
| 11:72139457:G:C | W156C | 0.989 |
| 11:72139457:G:T | W156C | 0.989 |
| 11:72139469:G:C | W160C | 0.989 |
| 11:72139469:G:T | W160C | 0.989 |
| 11:72139415:G:C | W142C | 0.988 |
| 11:72139415:G:T | W142C | 0.988 |
| 11:72139418:G:C | W143C | 0.987 |
| 11:72139418:G:T | W143C | 0.987 |
| 11:72139138:T:A | W116R | 0.980 |
| 11:72139138:T:C | W116R | 0.980 |
| 11:72138961:T:A | C57S | 0.978 |
| 11:72138962:G:C | C57S | 0.978 |
| 11:72139117:T:A | C109S | 0.976 |
| 11:72139118:G:C | C109S | 0.976 |
| 11:72138988:T:A | C66S | 0.975 |
| 11:72138989:G:C | C66S | 0.975 |
| 11:72139425:T:A | C146S | 0.974 |
| 11:72139426:G:C | C146S | 0.974 |
| 11:72139443:T:A | C152S | 0.974 |
| 11:72139444:G:C | C152S | 0.974 |
| 11:72139467:T:A | W160R | 0.974 |
| 11:72139467:T:C | W160R | 0.974 |
| 11:72139598:T:A | C169S | 0.974 |
dbSNP variants (sampled 300 via entrez): RS1000335892 (11:72139655 CT>C), RS1001095575 (11:72135385 C>A), RS1001210108 (11:72134248 C>T), RS1001277731 (11:72135532 T>A,C), RS1001369035 (11:72139565 G>T), RS1001587689 (11:72139366 A>G), RS1001827807 (11:72134037 G>T), RS1001913589 (11:72138271 C>T), RS1003032877 (11:72138510 G>A), RS1003370013 (11:72137326 C>A,T), RS1004369130 (11:72140030 AG>A), RS1004374975 (11:72134283 A>G), RS1004809728 (11:72135688 G>A,T), RS1005609562 (11:72137589 T>G), RS1006360781 (11:72136210 G>A,T)
Disease associations
OMIM: gene MIM:602469 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB clinical annotations
1 annotations.
| Variant | Type | Level | Drugs | Phenotypes |
|---|---|---|---|---|
| rs61734430 | Efficacy | 3 | pemetrexed | Mesothelioma;Non-Small Cell Lung Carcinoma |
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs61734430 | FOLR3 | 3 | 2.50 | 1 | pemetrexed |
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| sodium arsenate | increases abundance, increases expression | 1 |
| o,p’-DDT | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| chloropicrin | affects expression | 1 |
| jinfukang | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Coal | increases abundance, increases expression | 1 |
| Polychlorinated Biphenyls | affects expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.